Your browser doesn't support javascript.
loading
Impact of exclusion criteria for the DASISION and ENESTnd trials in the front-line treatment of a 'real-life' patient population with chronic myeloid leukaemia.
Latagliata, Roberto; Carmosino, Ida; Vozella, Federico; Volpicelli, Paola; De Angelis, Federico; Loglisci, Maria Giovanna; Salaroli, Adriano; De Luca, Maria Lucia; Montagna, Chiara; Serrao, Alessandra; Molica, Matteo; Diverio, Daniela; Nanni, Mauro; Mancini, Marco; Breccia, Massimo; Alimena, Giuliana.
Afiliação
  • Latagliata R; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • Carmosino I; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • Vozella F; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • Volpicelli P; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • De Angelis F; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • Loglisci MG; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • Salaroli A; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • De Luca ML; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • Montagna C; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • Serrao A; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • Molica M; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • Diverio D; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • Nanni M; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • Mancini M; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • Breccia M; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
  • Alimena G; Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy.
Hematol Oncol ; 35(2): 232-236, 2017 Jun.
Article em En | MEDLINE | ID: mdl-26648184
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva Idioma: En Ano de publicação: 2017 Tipo de documento: Article